klinikuri praqtikis erovnuli rekomendacia (gaidlaini)

• Cais, yavis miReba sakvebis miRebidan 1-2 saaTis Semdeg, vinaidan sakvebi
aRar imyofeba kuWSi da es produqtebi ver Seaferxeben rkinis Sewovas;
• rZis, yvelis miReba kvebaTa Soris;
• inhibitorebis Semcveli produqtebi moixmareba umetesad rkiniT Raribi
sakvebis miRebis dros. mag. sauzmed rkinis dabali Semcvelobis
marcvleuli (puri an simindis produqtebi) moixmareba CaisTan an rZis
produqtebTan erTad. es ki uzrunvelyofs kalciumis adeqvatur miwodebas
rkinis Sewovis Seferxebis gareSe;
• sakvebTan erTad C vitaminiT mdidari produqtebis (xilis wveni,
forToxali) miReba;
• rkiniTa da vitaminebiT fortificirebuli produqtebis miReba.
8. profilaqtika
rda profilaqtika 3 nawilisagan Sedgeba. (35, 36, 37, 38, 39).
I profilaqtika _ daavadebis ganviTarebis faqtorebis mocileba, maT Soris
kvebis swori racionis SemuSaveba.
II profilaqtika _ daavadebis adreuli gamovlena da mkurnaloba. am mizniT
im pirebs, romlebic miekuTvnebian rda ganviTarebis risk-jgufebs (menometroragia,
kuWis rezeqcia bilrot II wesiT, wvrili nawlavis rezeqcia da
a.S.) weliwadSi erTxel unda Seumowmdes hemoglobinis maCvenebeli daavadebis
drouli gamovlenisa da mkurnalobis mizniT [B] 46.
III garTulebebis Semcireba _ am mizniT orsulebs saplimentaciis mizniT
normaluri hemoglobinis pirobebSi eniSnebaT rkinis profilaqtikuri doza
30mg mTeli orsulobisa da SemdgomSi laqtaciisas 3 Tvis ganmavlobaSi (40,
41, 42) [B].
riskis jgufebSi Semaval pirebs, romlebic sxvadasxva mizeziT Rebuloben
rkiniT Rarib sakvebs, eZlevaT rCeva moixmaron rkiniTa da vitaminebiT
fortificirebuli sakvebi [A] (43, 44).
sisxlis donorebma yoveldRiurad unda miiRon 20mg rkina 45 [C].
hemoglobinisa da Hhematokritis normaluri maCveneblebi
(WHO/UNICEF 1997)
sqesi hemoglobinis g/l hematokriti
mamakacebi 130-180 40-50%
qalebi 120-160 36-44%
cxrili 6
20